… observational studies have shown an association between low circulating levels of 25-hydroxy-
vitamin D (25(OH)D) and an increase in inflammatory activity in Multiple Sclerosis (MS). …

… In this multicentre study, we demonstrated that cervical SC tissue damage is not restricted
to … as the potential effect of new medications in multicentre trials including patients with MS. …

… In this independent, multicenter, retrospective study, we investigated the short-term … (DMTs)
in patients with relapsing–remitting multiple sclerosis. Data of patients regularly attending 21 …

… Mycophenolate mofetil (MMF) is an immunosuppressive agent, sometimes used as a
disease-modifying therapy for multiple sclerosis (MS). Several studies have reported the relative …

… We performed a prospective multi-centre study using functional magnetic resonance …
expression and brain function in patients with multiple sclerosis (MS) at eight European sites (56 …

… a multi-centre study is conducted and results from such studies are applied. … multiple sclerosis
(MS) across Europe (results are described in this article). For the purposes of this study, PT …

Background: Optic neuritis (ON) may be the first symptom of a central nervous system
demyelinating, systemic or infectious disease but few patients experience recurrent episodes and …

… study confirm the results of a large Italian multicentre study in 648 patients with RRMS as
well as the results from a cross-sectional postal survey conducted in England and a study …

… To test these, we measured CTh from 3D T1-weighted scans of a multicentre cohort of healthy
controls (HC) and patients with RRMS and PMS at baseline and over 1-year of follow-up, …

… This is necessary for any department using the system for its own patients as well as for
multicentre studies since several records may have been registered from the same patient. …